Home > Insider Trading > Filing (0001209191-13-042692)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1197036	I Bruce Sachs	C/O Vertex Pharmaceuticals Incorporated 130 Waverly St. Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2013-08-29	1,690	$76.55	86,320	No	4	S	Direct
Common Stock	Disposition	2013-08-29	6,010	$77.29	80,310	No	4	S	Direct
Common Stock	Disposition	2013-08-29	600	$77.97	79,710	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $76.55 (range $75.83 to $76.82).
Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $77.29 (range $76.83 to $77.79).
Open market sales reported on this line occurred at a weighted average price of $77.97 (range $77.86 to $78.07).